Position in ZTS
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$204,148
-$88,886 QoQ
Shares Held
1,727
-25.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JAMES INVESTMENT RESEARCH, INC. holds $4,831,217 across 7 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
3,224 | $1,746,859 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
21,004 | $976,896 | |
| 3 | ALKS |
Alkermes plc.
|
10,285 | $538,882 | |
| 4 | EBS |
Emergent BioSolutions Inc.
|
61,963 | $519,249 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,027 | $449,376 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
4,650 | $384,927 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
5,940 | $215,028 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $204,148 | 1,727 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $293,034 | 2,329 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,627,371 | 11,122 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,299,014 | 14,742 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,689,722 | 16,336 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,730,055 | 16,756 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $3,966,018 | 20,299 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $3,662,403 | 21,126 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $3,619,909 | 21,393 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $4,278,192 | 21,676 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,455,416 | 19,861 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $3,344,834 | 19,423 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $3,153,205 | 18,945 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $2,529,892 | 17,263 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $3,873,927 | 26,124 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $5,773,956 | 33,591 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $6,717,010 | 35,617 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $7,785,777 | 31,905 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $6,456,902 | 33,259 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $6,296,917 | 33,789 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $5,324,713 | 33,812 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $5,509,826 | 33,292 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $3,913,810 | 23,667 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $3,458,614 | 25,238 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $3,076,651 | 26,142 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||